News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Microbicides news

Show

From To
Microbicides
The quest for the (vaginal) ring

The HIV prevention tablet is now available in South Africa. But, as the Bhekisisa Centre for Health Journalism reports, popping a pill every day to stay HIV-negative may not be for everyone. For young women, hassle-free alternatives are on the horizon.

Published
20 July 2019
From
Mail & Guardian
Microbicides
Novel HIV-1 Inhibitor Shows Promise for Future Treatment of HIV in Women

Avirulins may provide a valuable chemical foundation for the development of the next generation of prophylactic medications for HIV-1 in women, according to results of a study presented at American Society of Microbiology (ASM) Microbe 2019 held from June 20-24, 2019, in San Francisco, California.

Published
26 June 2019
From
Infectious Disease Advisor
HIV prevention policy
Vaginal ring can substantially impact HIV prevention, reveals mathematical model

New mathematical modelling study suggests that the dapivirine vaginal ring could substantially reduce HIV infections among South African women and be an affordable intervention depending on roll-out strategy.

Published
24 June 2019
From
Avert
PrEP science
TAF: Quick-dissolve combination PrEP insert is effective against HIV infections in monkeys; intermittent solo pill less so

Two studies in monkeys of experimental pre-exposure prophylaxis (PrEP) regimens featuring the drug tenofovir alafenamide (TAF) produced differing results when presented at last week’s Conference on Retroviruses

Published
13 March 2019
By
Gus Cairns
Microbicides
REACH trial comparing vaginal ring to PrEP for HIV prevention begins

The NIH announced the start of a clinical trial that will explore the preference among adolescent girls and young women between pre-exposure prophylaxis, or PrEP, and a vaginal ring for HIV prevention.

Published
24 February 2019
From
Healio
Long-acting HIV treatment
Emerging options: Doctors and advocates discuss treatment and prevention breakthroughs on the horizon

Long-acting injectables, implantables, the dapivirine ring, vaccines, antibodies, rectal douches, and two-drug regimens.

Published
30 January 2019
From
Positively Aware
Microbicides
Going local – prevention conference hears about rings, douches, and soluble suppositories

Last week’s HIV Research for Prevention conference (HIVR4P 2018) in Madrid heard a lot about oral pre-exposure prophylaxis (PrEP): not only its efficacy but also

Published
31 October 2018
By
Gus Cairns
PrEP science
Beyond Truvada – what is the future of PrEP?

Oral pre-exposure prophylaxis (PrEP) based on tenofovir disoproxil fumarate/emtricitabine (Truvada) has set a high bar for prevention effectiveness, but a range of alternative PrEP products are in

Published
31 October 2018
By
Roger Pebody
Microbicides
Vaginal rings, films, inserts or gels – it’s all about choice

There is no single HIV prevention technology which suits everyone – young African women who have tried four different vaginal products make different choices, with no one

Published
26 October 2018
By
Roger Pebody
Clinical trials
Making Clinical Trials of PrEP More Inclusive of Women, No Matter Their Pregnancy Status

Three new trials of HIV prevention drugs seek to answer directly a question that researchers inside and outside the field of HIV have explicitly avoided for years: How do drugs work -- and are they safe -- in pregnant and breastfeeding women?

Published
01 October 2018
From
The Body Pro
← First12345...26Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.